Cystatin C is an important kidney biomarker. Researchers first described Cystatin C as a gamma trace found in the urine and cerebrospinal fluid of patients with kidney failure. All nucleated human cells produce cystatin C. CST3 gene encodes cystatin C, which belongs to the gene family of type 2 cystatin. The CST3 gene is present in the cystatin locus on chromosome 9.
Cystatin C is a basic non-glycosylated protein characterized by long and short alpha-helices. Although researchers mainly use cystatin C levels and study the cystatin C glomerular filtration rate (GFR) to detect kidney disorders, recent studies also explore cystatin C’s role in predicting cardiovascular diseases and association with amyloid plaques in neurological disorders.
When you search for ‘what is cystatin c test’, you will come across other aliases for Cystatin C are cystatin 3, formerly known as post-gamma-globulin, neuroendocrine-basic polypeptide, and gamma trace.
Connect With Us For A Reference Call With Them!
NorthEast BioLab is by far the most responsive and thorough bioanalysis lab services CRO.
We partnered on several programs and found NorthEast BioLab responsive, collaborative, and reliable.
We trust NorthEast BioLab to design and execute the most streamlined and impactful bioanalytical projects.
We found their integrity as refreshing as readiness to provide creative scientific input and high-quality data.
We have worked with NorthEast BioLab for over ten years given their commitment to highest quality bioanalytical data.
NorthEast BioLab tremendously supported us in reproducing our critical lab discoveries for drug metabolism.
NorthEast BioLab always exceeds expectations on bioanalytical assay development, validation, and sample analysis.
NorthEast BioLab truly goes that extra mile, and we hope to continue enjoying seminal interactions with them.
NorthEast BioLab presents a science-based, hands-on, no-frills approach on the latest bioanalytical platforms.
We are thrilled to complete our bioanalytical studies with their top quality and incredibly responsive team.
We worked closely to implement the most efficient and cost-effective bioanalytical assay for our PK Studies.
Our projects with NorthEast BioLab include successful method development, validation, stability studies during Clinical Phase I – IV studies.
NorthEast BioLab provides critical insight, and are compliant with regulatory standards and industry best practices. We highly recommend them and look forward to working together again.
Our latest successful study was a pivotal bioequivalence study, where samples from a cross-over study with about 100 volunteers needed swift analysis.
This study, same as all other bioanalytical studies with NorthEast BioLab, was completed with top quality and reporting standard with incredible responsiveness.
As a small company, our vendors are key members of our project teams. The scientists at NorthEast BioLab are technical experts, who produce high-quality data, on-time, and on-budget.
At NorthEast BioLabs, we perform MSD, ELISA, and Luminex assays for testing cystatin C in biological and chemical samples. Below is a detailed Luminex assay protocol followed for a cystatin c test.
To assay for cystatin c , we begin with 200 μl of assay buffer in each well, shake it for 10 mins at RT, and decant it. Once we remove all the residues, we add 25 μl of the following components in appropriate wells: standard or control followed by assay buffer, matrix solution, diluted samples, and beads and are incubated overnight at 4 ℃. Once the beads capture an analyte, we add 50 μl of biotinylated detection antibody and incubate it for 1 hr at RT. We then incubate the wells with a 50 μl streptavidin-PE conjugate, a reporter molecule. Lastly, we add 100 μl of the sheath or drive fluid and read the plate on a Luminex platform.
The assay tests the cystatin c levels and identifies each microsphere through a fluorescent reporter signal system. The assay is sensitive (0.16 ng/ml – 0.24ng/ml) with an intra-assay precision of < 10% and inter-assay precision of < 20%. Moreover, the assay is highly accurate with 95% recovery (overnight protocol) and 105% recovery (2 hr protocol) in the serum matrix.
Research has linked kidney dysfunctions with increased mortality risk and cardiovascular diseases such as stroke, myocardial infarction, metabolic syndrome, peripheral arterial disease, and heart failure. At least 85% of plasma cystatin C clearance occurs in the kidneys. Kidneys clear plasma proteins that are ≤ 30 kilodaltons Thus, if glomerular membrane pores shrink in size, it will affect the filtration of cystatin C. Researchers have hypothesized this specific condition as “shrunken pore syndrome”.
Learn more about cystatin C tests, and functions in the following resources.
https://labtestsonline.org/tests/cystatin-c
https://acutecaretesting.org/en/articles/clarifying-the-confusion-of-gfrs-creatinine-and-cystatin-c
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692142/
https://www.sciencedirect.com/topics/medicine-and-dentistry/cystatin-c
https://www.kidney.org/atoz/content/cystatinC
Understand Multiplex Cytokine Analysis, Meso Scale Discovery (MSD) Cytokine Assay For Inflammation, Chemokines, Interleukins, Growth Factor …
Cystatin C is a 120 amino acid chain protein, virtually present in all the tissues. The cystatin c function is to efficiently inhibit cysteine proteases and lysosomal proteinases, making it an important cellular inhibitory protein.
The molecular weight of cystatin C is 13.3 kilodaltons, and glomerular filtration easily excretes them from the bloodstream. Proximal renal tubules completely catabolize cystatin C, and thus it does not return into the bloodstream. If GFR and kidney functions decline, cystatin C blood level rises proportionally. Cross-sectional studies and cystatin c assays show serum cystatin C antibody levels to be more precise than serum creatinine levels for testing kidney functions. When compared to creatinine, muscle mass, gender, age, and ethnicity do not influence cystatin C levels largely. Moreover, studies suggest cystatin C might be a great candidate for signaling preclinical kidney dysfunction.
Brain-Derived Neurotrophic Factor
Granulate Colony Stimulation Factor
Epidermal growth factor
Fas Ligand
Granulocyte Macrophage Colony Stimulating Factor
Leukemia Inhibitory Factor
Luteinizing hormone
Macrophage Migration Inhibitory Factor
Interferon Beta
Interferon Gamma
Transforming Growth Factor Beta 1
B Type Natriuretic Peptide
Glial Fibrillary Acidic Protein
Cystatin C
Hepatocyte Growth Factor
Interferon Alpha 2
Tumor Necrosis Factor Alpha
